Home › Funds › Palo Alto Investors LP › STOK

Palo Alto Investors LP position in STOK

STOKE THERAPEUTICS INC · Health Care

Palo Alto Investors LP reported holding 84,631 shares of STOK (STOKE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.2M, representing 0.33% of its reported portfolio and ranking #37 among its reported holdings. Palo Alto Investors LP has disclosed STOK holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)84.63K sh
Reported value held$2.20M
Portfolio Weight0.33%
First reportedQ1 2024
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Palo Alto Investors LP's STOK position evolved

Palo Alto Investors LP first disclosed a stake in STOK in Q1 2024 at 125,861 shares (US$1.7M). The position peaked in Q2 2026 at 84,631 shares, worth US$2.8M. Across 11 filings, Palo Alto Investors LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 84,631 shares valued at US$2.2M. Notable position changes include a 32% trim in Q4 2025 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 125.86K $1.70M New
Q2 2024 125.86K $1.70M Hold
Q3 2024 125.86K $1.55M Hold
Q4 2024 125.86K $1.39M Hold
Q1 2025 125.86K $836.98K Hold
Q2 2025 125.86K $1.43M Hold
Q3 2025 105.43K $2.48M Reduce
Q4 2025 72.02K $2.29M Reduce
Q1 2026 84.63K $2.76M Add
Q2 2026 84.63K $2.77M Hold
Q3 2026 84.63K $2.20M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About STOK and 13F data

STOK (STOKE THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$146.2M), Lynx1 Capital Management LP (US$101.3M), Redmile Group, LLC (US$100.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding STOK

All STOK fund holders →

FAQ

How long has Palo Alto Investors LP held STOK?

Palo Alto Investors LP has disclosed STOK holdings in 11 of the last 11 reported quarters, going back to Q1 2024.

What is Palo Alto Investors LP's current position in STOK?

As of Q3 2026, Palo Alto Investors LP holds 84.63K shares of STOK (STOKE THERAPEUTICS INC), valued at $2.20M, representing 0.33% of its reported portfolio and ranking #37.

Has Palo Alto Investors LP been buying or selling STOK?

In the latest 13F filing (Q3 2026), Palo Alto Investors LP held unchanged its position in STOK. The position peaked in Q2 2026 at 84.63K shares.

Which other funds hold STOK?

Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.